"Heron Therapeutics, Inc, a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations to improve medical care, announced that the company has entered into a settlement agreement with Mylan Pharmaceuticals, Inc. (Mylan), a Viatris Inc, company, to resolve the ongoing patent litigations between the parties in the US District Court for the District of Delaware related to Cinvanti (aprepitant) injectable emulsion and Aponvie (aprepitant) injectable emulsion.
Pursuant to the terms of the settlement agreement, Heron Therapeutics has granted Mylan a license under the Orange Book-listed patents for Cinvanti and Aponvie (the ""Heron Patents""), to market generic versions of Cinvanti and Aponvie in the United States beginning June 1, 2032, or earlier under certain customary circumstances.
These patent litigations were initiated by Heron Therapeutics in September 2023 and January 2024 in response to Mylan's abbreviated new drug applications seeking United States Food and Drug Administration approval of generic versions of Cinvanti and Aponvie, respectively, in the United States prior to the expiration of the Heron Patents in 2035.
In connection with the settlement, Heron Therapeutics and Mylan will file a proposed stipulation and order of dismissal with the US District Court for the District of Delaware requesting that the Court dismiss the pending litigations between the parties.
Heron Therapeutics’ advanced science, patented technologies, and innovative approach to drug discovery and development have allowed the company to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!